Wenjuan Yu

机构：Zhejiang Cancer Hospital, Zhejiang Technical Institute of Economics, Zhejiang Lab, First Affiliated Hospital of Jinan University, First Affiliated Hospital Zhejiang University, Hubei University, Zhejiang University · ORCID：0000-0002-5439-141X

发表论文 213 篇 · 总被引 1520 次 · h-index 21

代表论文

• TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study (2026 · Annals of Hematology · 被引 3)
• The METTL3-YTHDC1 axis mediates architectural RNA m6A modification to modulate the integrity of chromatin TADs in MLLr + AML genome (2025 · Molecular Cancer · 被引 2)
• Clinical characteristics and survival outcomes of thymic mucosa‐associated lymphoid tissue lymphoma: A multicenter analysis of 82 patients (2025 · Cancer · 被引 2)
• Glofitamab combined with tislelizumab in relapsed/refractory diffuse large B-cell lymphoma: a single-center pilot trial (2025 · Blood Cancer Journal · 被引 2)
• Olverembatinib plus immunotherapy versus olverembatinib plus allogeneic hematopoietic cell transplantation in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (2026 · Blood Cancer Journal · 被引 1)
• Revealing tumor microenvironmental heterogeneity and prognostic value in angioimmunoblastic T-cell lymphoma via spatial transcriptome sequencing (2026 · Cell Death and Disease · 被引 1)